Nanospectra Biosciences Initiates Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue; Goal to Enroll Up to 60 Patients in Twelve Month Study Accrual Period

Media coverage

• Title	Nanospectra Biosciences Initiates Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue; Goal to Enroll Up to 60 Patients in Twelve Month Study Accrual Period
  Media name/outlet	PR Newswire
  Country/Territory	United States
  Date	4/02/20
  Persons	Ardeshir Rastinehad,